Literature DB >> 24080599

Gastrointestinal cancer: AVEX: opportunities in elderly patients with mCRC.

Lisa Hutchinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24080599     DOI： 10.1038/nrclinonc.2013.178

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.

Authors:  David Cunningham; Istvan Lang; Eugenio Marcuello; Vito Lorusso; Janja Ocvirk; Dong Bok Shin; Derek Jonker; Stuart Osborne; Niko Andre; Daniel Waterkamp; Mark P Saunders
Journal:  Lancet Oncol       Date:  2013-09-10       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.